| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/16/1993 | WO1993017666A1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
| 09/16/1993 | WO1993017663A1 Pharmaceutical inhalation compositions |
| 09/16/1993 | WO1993017655A1 Topical aromatic releasing compositions |
| 09/16/1993 | WO1993017633A1 Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like |
| 09/16/1993 | WO1993017559A1 Method of treating infectious disease, method of preventing putrefaction of cosmetic, and antibacterial/antifungal agent and cosmetic |
| 09/16/1993 | WO1993017555A1 N,n'-disubstituted guanidines and their use as excitatory amino acid antagonists |
| 09/16/1993 | WO1993017553A1 Decontaminating blood components with 8-methoxypsoralen |
| 09/16/1993 | WO1993016087A3 Amadori reaction compounds and products, process for their manufacture, and their use |
| 09/16/1993 | DE4207822A1 Use of 3-phenyl-pyridazine derivs. - to prepare medicaments for treating diseases associated with over-release of cytokines and/or leukotriene(s) |
| 09/16/1993 | CA2131992A1 Antipyretic and analgesic methods and compositions containing optically pure r-etodolac |
| 09/16/1993 | CA2131990A1 Pharmaceutical composition having site-specific delivery |
| 09/16/1993 | CA2131802A1 Antipyretic and analgesic methods and compositions containing optically pure r(-)ketoprofen |
| 09/16/1993 | CA2131801A1 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 09/16/1993 | CA2131787A1 Antipruritic |
| 09/16/1993 | CA2131693A1 Antiviral nucleoside analogues |
| 09/16/1993 | CA2131458A1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
| 09/16/1993 | CA2131444A1 Dna encoding taurine and gaba transporters and uses thereof |
| 09/16/1993 | CA2131381A1 Nitrogen containing heterocyclic compounds useful as pharmaceuticals |
| 09/16/1993 | CA2131371A1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
| 09/16/1993 | CA2131305A1 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
| 09/16/1993 | CA2131024A1 Treatment and prophylaxis of diseases caused by parasites, or bacteria |
| 09/16/1993 | CA2131010A1 Cyclic ketal derivatives |
| 09/16/1993 | CA2130938A1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 09/16/1993 | CA2130905A1 Halichondrins and related compounds |
| 09/16/1993 | CA2130359A1 Compositions and methods for modulating rna |
| 09/16/1993 | CA2129146A1 Imidazole, triazole and tetrazole derivatives |
| 09/16/1993 | CA2129145A1 Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them |
| 09/16/1993 | CA2117592A1 N,n'-disubstituted guanidines and their use as excitatory amino acid antagonists |
| 09/15/1993 | EP0560730A2 New derivatives of beta-amino acids with anti-thrombotic activity |
| 09/15/1993 | EP0560669A1 Piperazinyl-and piperidinyl-cyclohexenes and cyclohexanes |
| 09/15/1993 | EP0560633A1 Use of tropane derivatives for the manufacture of a medicament for the treatment of neurodegenerative diseases |
| 09/15/1993 | EP0560613A1 Antimicrobial carbapenem derivatives, their preparation and their therapeutic use |
| 09/15/1993 | EP0560604A1 Cinnoline-3-carboxylic acid derivatives as 5-HT3 antagonists |
| 09/15/1993 | EP0560554A2 Antitumor compositions and methods of treatment |
| 09/15/1993 | EP0560541A1 Method of treating dry skin |
| 09/15/1993 | EP0560407A1 Pharmaceutically active compounds |
| 09/15/1993 | EP0560399A1 Use of substituted 3,4-dihydro-2H-benzopyrans as medicament against disorders of the urethra |
| 09/15/1993 | EP0560389A1 Lactone with immunosuppressive activity |
| 09/15/1993 | EP0560365A1 Cephalosporin derivative |
| 09/15/1993 | EP0560348A1 Thieno 3,2-b pyridine derivatives for the treatment of gastrointestinal disorders |
| 09/15/1993 | EP0560330A2 Substituted benzimidazolyl derivatives, therapeutic agents containing them and process for their preparation |
| 09/15/1993 | EP0560329A1 Pranoprofen-containing, suspending medicinal composition |
| 09/15/1993 | EP0560284A1 Prophylactic and remedial preparation for diseases attendant on hyperglycemia, and wholesome food |
| 09/15/1993 | EP0560275A1 Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients |
| 09/15/1993 | EP0560274A1 Antiherpes peptide derivatives having a ureido N-terminus |
| 09/15/1993 | EP0560269A1 Substituted pyrrolidine derivatives as HIV protease inhibitors |
| 09/15/1993 | EP0560268A1 Substituted pipecolinic acid derivatives as HIV protease inhibitors |
| 09/15/1993 | EP0560267A1 Isosteric antiherpes peptide derivatives |
| 09/15/1993 | EP0560232A1 Novel 7-aminolabdanes, a process for their preparation and their use as pharmaceutical agents |
| 09/15/1993 | EP0560231A1 Pyrazolo(3,4-a)acridine derivatives as analgesics |
| 09/15/1993 | EP0560207A1 Composition based on ibuprofen, for oral usage |
| 09/15/1993 | EP0560177A1 Imidazole derivatives having biphenylsulphonylurea or biphenylsulfonylurethane side chains, process for their production and use thereof |
| 09/15/1993 | EP0560163A1 Imidazolylmethyl substituted phenylacetic-acid amides, process for their preparation and their pharmaceutical application |
| 09/15/1993 | EP0560162A1 Imidazolylmethyl substituted phenylacetic-acid amides, process for their preparation and their pharmaceutical application |
| 09/15/1993 | EP0560156A2 Pseudorabies virus polynucleotids and their use in the production of virus-resistant eucaryotic cells |
| 09/15/1993 | EP0560149A1 BU-4641V, an antibacterial antiviral and antitumor antibiotic |
| 09/15/1993 | EP0560147A1 16-Membered macrolide derivative having sustained antibacterial activity in plasma, synthesic intermediate thereof and process for producing the same |
| 09/15/1993 | EP0560138A1 Drug formulations by liposomes and the process for their manufacture |
| 09/15/1993 | EP0560136A1 Neuroprotective drug |
| 09/15/1993 | EP0560092A1 Tablets, granulates and pellets with a high drug content for highly concentrated solid administration forms |
| 09/15/1993 | EP0559898A1 Anilide derivative |
| 09/15/1993 | EP0559891A1 Thienodiazepine compound and its use |
| 09/15/1993 | EP0559856A1 Antimicrobial preservation of platelets and blood factors |
| 09/15/1993 | EP0559845A1 Use of compounds in preventing endotoxin shock |
| 09/15/1993 | EP0559838A1 Ecteinascidins 736 and 722. |
| 09/15/1993 | EP0559825A1 Method and device for treating tobacco addiction. |
| 09/15/1993 | EP0559815A1 Optically active thiazoloisoindolinone derivatives with an antiviral action. |
| 09/15/1993 | EP0559812A1 Composition containing antihistamine h 2? receptor antagonists and bioadhesive material |
| 09/15/1993 | EP0559804A1 Diaper rash treatment |
| 09/15/1993 | EP0559793A1 Hiv protease inhibitors |
| 09/15/1993 | EP0559774A1 Individual stereoisomers of 7- 3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents |
| 09/15/1993 | EP0559755A1 Substituted 5-aryl imidazoles |
| 09/15/1993 | EP0559752A1 Optical isomers of 7- 3-(1,1-dialkylmethyl-1-amino-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents |
| 09/15/1993 | EP0559744A1 Combinations of vanilloid compounds and nucleoside antiviral compounds for treatment of herpes infections |
| 09/15/1993 | EP0559728A1 Aromatic aldehydes and derivatives and pharmaceutical compositions thereof useful for the treatment of skin diseases and arthritis |
| 09/15/1993 | EP0559724A1 Benzofuran and benzthiophene derivatives |
| 09/15/1993 | EP0559702A1 Retarded-action urapidil formulation. |
| 09/15/1993 | EP0559700A1 Novel pilocarpine derivatives and process for their preparation |
| 09/15/1993 | EP0559695A1 New pyridine derivatives, methods of preparing them and their use as drugs. |
| 09/15/1993 | EP0559647A1 Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase |
| 09/15/1993 | EP0559645A1 Composition for solid pharmaceutical preparations containing active vitamins d 3? and process for preparation thereof |
| 09/15/1993 | EP0554363A4 Alteration of rate and character of hair growth |
| 09/15/1993 | EP0517836A4 Method and product for promoting hair growth and treating skin conditions |
| 09/15/1993 | EP0494904B1 Device for oral administration of an active principle for preventive treatment of caries in babies |
| 09/15/1993 | EP0490991B1 Dosage form for administering oral hypoglycemic glipizide |
| 09/15/1993 | EP0419610B1 New leukotriene b4 derivatives, process for producing them and their use as drugs |
| 09/15/1993 | EP0409999B1 Liquid preparation for intraocular perfusion |
| 09/15/1993 | EP0409971B1 Weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin |
| 09/15/1993 | EP0397831B1 Treatment of obesity |
| 09/15/1993 | EP0387300B1 Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained |
| 09/15/1993 | CN1076200A New derivatives of beta-amino acids |
| 09/15/1993 | CN1076197A Novel compounds |
| 09/15/1993 | CN1076196A Process for the synthesis of ergoline derivatives |
| 09/15/1993 | CN1076195A Benzanilide derivatives |
| 09/15/1993 | CN1076192A Imidazole derivative with side chain of phenylsulfthiourea or phenylsulfthiourea alkylate, method for preparing same and application thereof |
| 09/15/1993 | CN1076186A Cryogenic rectification system with argon heat pump |
| 09/15/1993 | CN1076124A A process for preparing oral drug coated containing compounds unstable to acid |
| 09/15/1993 | CN1076112A Change of lentinan powder to liquid for intravenous injection |
| 09/15/1993 | CN1076111A Antiviral cantharidate preparation and preparing process thereof |
| 09/15/1993 | CN1076109A Prescription and productive process for "Xiao Kuining" tablets for curing ulcer |